Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mazars USA was the U.S. member firm of the global Mazars network, providing audit, tax, accounting, advisory, and consulting services rather than developing therapeutics or healthcare products. The business served a range of industries, including healthcare and life sciences clients, but it was not itself a biotech, pharma, medtech, or healthcare operating company. Mazars USA operated as a professional-services firm and was acquired by FORVIS as part of the transaction that created the Forvis Mazars brand in the United States effective June 1, 2024. As a result, Mazars USA no longer appears to operate as an independent standalone company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mazurs USA.